Registration Options

Activity Date: 04/18/2023

Session Time and Location

The live session is complete.

Target Audience

We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.

Session Summary

Access the Free Virtual LAI Training Program

This Long-Acting Injectable Preparation and Administration Learning Lab provides pharmacists with an opportunity to prepare and administer psychotropic LAIs via gluteal and deltoid simulation muscles. Using models of the muscles, facilitators will provide instruction, assist with locating landmarks for the injection site, and provide feedback on intramuscular and subcutaneous injection techniques. LAI manufacturers have been invited to participate in the learning lab to provide information on specific LAIs and additional practice with product demonstration kits. Manufacturer representatives are able to provide education on the safe and proper use of LAIs. The goal of this activity is to enhance comfort with administering these medications and expand patient access to mental health care.

Up to 300 participants can be accommodated at this learning lab. The lab is a hands-on, interactive event that allows participants to come and go as they please within the timeframe offered. It is estimated that learners will spend 30 minutes visiting the stations in the Learning Lab and ACPE credit is available accordingly. However, spend as much time as you need to practice and gain comfort with preparing and administering the injections! The first 300 participants will receive a free, printed copy of the LAI clinical pocket guide. This guide is available electronically as well and is designed for easy access in practice to quickly locate key information about each of the available psychotropic LAIs.

 

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Mary Borovicka, PharmD, BCPP
Megan Ehret, PharmD, BCPP, MS
Jordan Haygood, PharmD, BCPP
Jerry McKee, PharmD, BCPP, MS
Tawny Smith, PharmD, BCPP

View biographical information

Learning Objectives

  1. Explain the process for preparing psychotropic LAIs for administration.
  2. Identify landmarks for the deltoid and gluteal muscles prior to administration of psychotropic LAIs.
  3. Demonstrate appropriate injection technique for intramuscular and subcutaneous injections.

Continuing Education Credit and Disclosures

Activity Date: 04/18/2023
ACPE Contact Hours: 0.5
ACPE Number: 0284-0000-23-048-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.